Nalwa Sons Investments Balance Sheet Health
Financial Health criteria checks 6/6
Nalwa Sons Investments has a total shareholder equity of ₹126.5B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹145.6B and ₹19.0B respectively. Nalwa Sons Investments's EBIT is ₹893.8M making its interest coverage ratio 28833.7. It has cash and short-term investments of ₹141.9B.
Key information
0%
Debt to equity ratio
₹0
Debt
Interest coverage ratio | 28833.7x |
Cash | ₹141.86b |
Equity | ₹126.53b |
Total liabilities | ₹19.03b |
Total assets | ₹145.56b |
Recent financial health updates
No updates
Recent updates
Nalwa Sons Investments Limited's (NSE:NSIL) Business Is Trailing The Market But Its Shares Aren't
Oct 16Nalwa Sons Investments Limited's (NSE:NSIL) Shares Climb 27% But Its Business Is Yet to Catch Up
Jun 29Here's Why Nalwa Sons Investments (NSE:NSIL) Has Caught The Eye Of Investors
Nov 09If EPS Growth Is Important To You, Nalwa Sons Investments (NSE:NSIL) Presents An Opportunity
Aug 01Should You Be Adding Nalwa Sons Investments (NSE:NSIL) To Your Watchlist Today?
Dec 23Does Nalwa Sons Investments' (NSE:NSIL) CEO Salary Compare Well With The Performance Of The Company?
Feb 17What Type Of Returns Would Nalwa Sons Investments'(NSE:NSIL) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Dec 07Did Nalwa Sons Investments' (NSE:NSIL) Share Price Deserve to Gain 35%?
Aug 25Financial Position Analysis
Short Term Liabilities: NSIL's short term assets (₹145.2B) exceed its short term liabilities (₹581.0K).
Long Term Liabilities: NSIL's short term assets (₹145.2B) exceed its long term liabilities (₹19.0B).
Debt to Equity History and Analysis
Debt Level: NSIL is debt free.
Reducing Debt: NSIL has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Debt Coverage: NSIL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NSIL has no debt, therefore coverage of interest payments is not a concern.